A polygenic risk score (PRS) based on genes associated with endothelial cell function identifies patients at a higher risk of coronary artery disease, according to a new study. The risk score, which ...
Emmecell receives FDA RMAT designation for EO2002, advancing development of its regenerative cell therapy for corneal endothelial disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results